Skip to main content

Keep up with the latest developments in diabetes

News, expert interviews, & educational resources


05-04-2021 | Medications | News

Objective assessment of medication taking advised to reduce type 2 diabetes complications

Suboptimal medication-taking identified through urine testing is associated with a higher prevalence of microvascular and macrovascular complications in people with type 2 diabetes than found with consistent usage, report researchers.

Stay informed with Medicine Matters

Get the latest developments in diabetes delivered straight to your inbox

MOST READ | Type 1 diabetes

04-20-2021 | DUKPC 2021 | Conference coverage | News

Routine autoantibody measurement advised for suspected adult type 1 diabetes

A majority of adults with clinically diagnosed type 1 diabetes but no islet autoantibodies have a low genetic risk for the condition, suggesting misdiagnosis, report researchers.

MOST READ | Cardiovascular disorders

04-20-2021 | Risk factors | News

Trigger finger may warn of impending CVD complications in type 2 diabetes

People with type 2 diabetes who have trigger finger are likely at an increased risk for cardiovascular disease, say researchers.

MOST READ | SGLT2 inhibitors

04-13-2021 | Dapagliflozin | News

DAPA-HF: Consistent benefits of dapagliflozin in men and women

Adding dapagliflozin to standard care improves outcomes for people with heart failure and reduced ejection fraction irrespective of sex, suggests a prespecified subgroup analysis of the DAPA-HF trial.

SGLT2 inhibitor use in type 2 diabetes management

Learn about prescribing these medications with guidance from the Improving Diabetes Steering Committee.

  • » A prescribing tool to inform prescribing decisions for SGLT2 inhibitors
  • » SGLT2 inhibitors: Key evidence and implications for clinical practice
  • » Translating SGLT2 inhibitor cardiovascular evidence into practice
  • » This content is intended only for UK healthcare providers and was made possible by educational funding provided by Napp Pharmaceuticals Ltd.

MOST READ | Diabetes devices & technology

04-07-2021 | Flash glucose monitoring | News

Real-world data support benefits of flash glucose monitoring

Flash glucose monitoring is associated with small but sustained improvements in glycemic control and a reduction in severe hypoglycemia relative to self-monitoring of blood glucose in type 1 diabetes, observational data show.

Flash glucose monitoring technology

Browse new slide sets summarizing the latest results from real-world studies.


Interviews with experts on diabetes patient care

Image Credits